Baptist Health Herbert Wertheim Cancer Institute Becomes a Care Partner of Memorial Sloan Kettering Cancer Center (MSK) - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Baptist Health Herbert Wertheim Cancer Institute Becomes a Care Partner of Memorial Sloan Kettering Cancer Center (MSK)

  • By

  • November 19, 2026

  • 4 min

Share

Clinical Scorecard: Baptist Health Herbert Wertheim Cancer Institute Becomes a Care Partner of Memorial Sloan Kettering Cancer Center (MSK)

At a Glance

CategoryDetail
ConditionClinical topic addressed by the source article: Baptist Health Herbert Wertheim Cancer Institute Becomes a Care Partner of Memorial Sloan Kettering Cancer Center (MSK)
Key MechanismsMechanisms or clinical associations described in the source article.
Target PopulationCancer patients in South Florida.
Care SettingCare setting described in the source article.

Key Highlights

  • Wertheim Cancer Institute was designated an MSK Care Partner after an extensive evaluation of its clinical care, resources, and capabilities.
  • The Institute achieved alignment with MSK’s Standards of Care™ following review of clinical infrastructure, care processes, and clinical outcomes.
  • The partnership supports access to MSK clinical advancements, expanded research and clinical trial opportunities, and enhanced physician education while patients continue care with local oncologists.
  • Physicians from both institutions will plan and conduct clinical trials in medical oncology, radiation oncology, and surgery.
  • Patients seeking second opinions will have access to a streamlined referral process and an expedited pathway for pathology second opinions.

Guideline-Based Recommendations

Diagnosis

    Management

      Monitoring & Follow-up

        Risks

          Patient & Prescribing Data

          Not specified; the source describes a partnership serving cancer patients in South Florida.

          No medication or prescribing recommendations are specified. The partnership provides access to MSK clinical advancements, research and clinical trial opportunities, physician education, and second-opinion pathways.

          Clinical Best Practices

          • Wertheim Cancer Institute’s alignment with MSK’s Standards of Care™ followed an intensive review of clinical infrastructure, care processes, and clinical outcomes.
          • Physicians from Wertheim Cancer Institute and MSK will collaborate on clinical trials in medical oncology, radiation oncology, and surgery.
          • The partnership includes enhanced physician education and access to MSK expertise while patients remain under the care of local oncologists.

          Related Resources & Content

          Original Source(s)

          Related Content